Want to join the conversation?
$BEN 3Q15 Q&A: Warren of Morningstar asked about flow generation if it is a matter of performance or meeting sales efforts in place. Gregory answered for consistency in last five years on Templeton side with the dollar and their strategy of not hedging and volatility, that's BEN's core global equity offering.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.